Overview
Hydra Medical Investments, LLC, founded in 2014, operates primarily in the wholesale distribution of surgical and other medical products. The company, conducting business under the name Hydra Medical, is identified by its CAGE Code 7G9C5 and DUNS number 079977887. Notably, it is registered with the United States Government’s System for Award Management (SAM), allowing eligibility for federal contracts.
Location and Structure
Based in Texas, USA, the company is registered as a limited liability company (LLC). Its principal address and mailing location is 4609 Boulder Run, Fort Worth, TX 76109-3217.
Operations
Hydra Medical Investments, LLC is involved in professional logistics management services specifically within the medical logistics arena and offers procurement services including purchasing. It primarily operates under the NAICS code 314120, indicative of its role in wholesaling medical products.
Leadership
The company is led by Chris B. Hardy, serving as the President. Chris Hardy is a key figure for both government and electronic business dealings, reflecting his pivotal role in the organization. His contact details are available, including email chardy1972@gmail.com and phone number 214-748-3647.
Online Presence
The corporate domain for Hydra Medical Investments is identified as www.hydramedical.com. However, the site does not provide extensive details on products or additional company specifics.
Recent Achievements & Activities
Hydra Medical Investments has recently secured an $86,668.40 federal contract reserved for service-disabled veteran-owned small businesses. This contract underscores the company’s competitive engagement within the government contracting sector.
Key Facts
- Business Start Date: June 12, 2014
- Initial SAM Registration Date: September 16, 2015
- SAM Registration Expiration Date: September 2, 2020
- Last Update: September 3, 2019
This profile highlights Hydra Medical’s strength in medical logistics and its strategic positioning within federal contracting avenues. Although there is no specific activity recorded post the SAM expiration date, Hydra Medical's logistics and procurement acumen point to sustained industry influence.
Competitor Profiling for Hydra Medical Investments, LLC
Overview
Alongside its Texas operations, Hydra Medical Investments, LLC is also noted to have activities in Wilmington, North Carolina. The company is involved in healthcare investments across pharmaceuticals, medical devices, and biotechnology.
Competitors
Hydra Medical Investments, LLC operates in a competitive environment with notable adversaries including:
1. Alpha Partners: Engages in diverse investment portfolios across the healthcare domain.
2. Blue Ocean and Cabot Partners Limited: Competitors providing expansive investment strategies in life sciences and healthcare.
3. Acetylon Pharmaceuticals, Quartet Medicine, and Arena: These entities, focused on pharmaceutical innovation, present direct competition to the interests pursued by Hydra Medical Investments.
Relevant Industry Trends
The healthcare investment sector is characterized by substantial activity from private equity firms targeting growth in biotechnology and pharmaceuticals:
- Leading Private Equity Firms:
- Carlyle Group and KKR: They are global leaders in healthcare investments, managing substantial assets with comprehensive healthcare portfolios.
- TPG Capital, Blackstone Group, and Bain Capital: Each of these firms commands extensive healthcare investments, with billions in dedicated capital.
Strategic Considerations
To expand its healthcare investment footprint, Hydra Medical Investments, LLC should contemplate partnerships or strategic collaborations with prominent private equity firms. Aligning with the strategies of larger entities such as Carlyle and Bain, which focus on biotechnology and medical device innovations, may facilitate shared investment opportunities and broader industry impact.
Understanding and leveraging the competitive landscape alongside insights from these leading private equity strategies can bolster Hydra Medical Investments’ market position and industry influence.
